Last €0.93 EUR
Change Today -0.005 / -0.53%
Volume 0.0
VCC On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:08 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alain P. Rolland Pharm.D., Ph.D.

Former Executive Vice President of Product Development, Vical Incorporated
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

54$922,162
As of Fiscal Year 2013

Background*

Dr. Alain P. Rolland, Pharm.D., Ph.D. served as an Executive Vice President of Product Development at Vical Inc.since January 2009. Dr. Rolland served as a the Senior Vice President of Product Development at Vical Inc. since April 2004 to January 2009. Dr. Rolland joined Vical Inc. in August 2002. He served as Vice President of Product Development at Vical Inc. from August 2002 to April 2004. Dr. Rolland served as a Vice President of Research at Genemedicine Inc., since ...

Read Full Background

Corporate Headquarters*

10390 Pacific Center Court
San Diego, California 92121

United States

Phone: 858-646-1100
Fax: 858-646-1150

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
Université Rennes 1
Doctorate
Université Rennes 1
PhD
Université Rennes 1

Other Affiliations*

Annual Compensation*

Salary$346,698
Bonus$285,600
Total Annual Compensation$632,298

Stock Options*

Restricted Stock Awards$72,904
All Other Compensation$6,181
Exercisable Options646,251
Total Number of Options646,251

Total Compensation*

Total Annual Cash Compensation$638,479
Total Short Term Compensation$632,298
Other Long Term Compensation$79,085
Total Calculated Compensation$922,162
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VCC:GR €0.93 EUR -0.005

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Corporate Secretary and Director
GenVec, Inc.
$316.3K
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$436.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$312.5K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.